high quality [clinical evaluation of combination chemotherapy

  • innovent and lilly release clinical trial results

    Innovent and Lilly Release Clinical Trial Results

    ORIENT-11 is a randomized, double-blind, Phase 3 clinical trial evaluating the efficacy and safety of TYVYT® (sintilimab injection) or placebo in combination with ALIMTA® (pemetrexed) and

  • [clinical evaluation of effects and improvement in quality

    [Clinical evaluation of effects and improvement in quality

    [Clinical evaluation of effects and improvement in quality of life from palliative therapy of combination chemotherapy with Furtulon and consecutive low-dose cisplatin in cases of unresectable advanced gastrointestinal carcinoma]. [Article in Japanese] Tong F(1), Liu H, Wang S, Yang D, Gu J, Qiao X, Zhang J.

  • evaluation of combination chemotherapy | clinical cancer research

    Evaluation of Combination Chemotherapy | Clinical Cancer Research

    Evaluation of drug-drug interaction is important in all areas of medicine and, in particular, in cancer chemotherapy where combination therapy is commonly used. The nature and quantitative extent of drug interaction is usually determined in in vitro studies. Two recent reviews describe the various evaluation methods (1, 2). These methods fall

  • evaluation of combination nivolumab and ipilimumab

    Evaluation of Combination Nivolumab and Ipilimumab

    Results Among the 39 patients included in this subgroup analysis of a phase 2 clinical trial (20 men, 19 women; mean [range] age, 65 [37-81] years), the objective response rate was 23% (n = 9) with a disease control rate of 44% (n = 17); all responders had received prior chemotherapy, and none had a microsatellite unstable tumor. Responses were

  • high dose lansoprazole combined with metronomic chemotherapy

    High dose lansoprazole combined with metronomic chemotherapy

    Twenty-four companion animals (22 dogs and 2 cats) were treated adding to their metronomic chemotherapy protocol the pump inhibitor lansoprazole at high dose, and a water alkalizer. Their responses have been evaluated by clinical and instrumental evaluation and matched to those of the control group.

  • clinical development of new drug–radiotherapy combinations

    Clinical development of new drug–radiotherapy combinations

    The design of a recent clinical study (NCT02264678) enabled increased doses of the ATR inhibitor AZD6738 in combination with chemotherapy and/or novel anticancer agent; this design could be

  • clinical evaluation of two dosages and schedules

    Clinical evaluation of two dosages and schedules

    1. Oncol Rep. 1998 Nov-Dec;5(6):1499-505. Clinical evaluation of two dosages and schedules of ifosfamide in combination with cisplatin in neo-adjuvant chemotherapy of patients with advanced (stage III-IV) head and neck squamous cell carcinoma: a phase II randomized study.

  • innovent and lilly release clinical trial results

    Innovent and Lilly Release Clinical Trial Results

    ORIENT-11 is a randomized, double-blind, Phase 3 clinical trial evaluating the efficacy and safety of TYVYT® (sintilimab injection) or placebo in combination with ALIMTA® (pemetrexed) and

  • drug resistance and the role of combination chemotherapy

    Drug Resistance and the Role of Combination Chemotherapy

    A. M. Brufsky, S. Hurvitz, E. Perez et al., “RIBBON-2: a randomized, double-blind, placebo-controlled, phase III trial evaluating the efficacy and safety of bevacizumab in combination with chemotherapy for second-line treatment of human epidermal growth factor receptor 2-negative metastatic breast cancer,” Journal of Clinical Oncology, vol

  • innovent and lilly release clinical trial results

    Innovent and Lilly Release Clinical Trial Results

    SUZHOU, China, Aug. 8, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ('Innovent') (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines f...

  • combination chemotherapy: history, benefits, and risks

    Combination Chemotherapy: History, Benefits, and Risks

    Combination chemotherapy refers simply to the use of more than one chemotherapy medication at a time to treat cancer. In the past, cancer was often treated with a single drug, but current treatments for many types of cancer use a combination of two or more different drugs simultaneously.

  • assessing the efficacy and safety of iv vitamin c

    Assessing the Efficacy and Safety of IV Vitamin C

    Assessing the Efficacy and Safety of IV Vitamin C in Combination With Standard Chemotherapy for Pancreatic Ca The safety and scientific validity of this study is the responsibility of the study sponsor and investigators.

  • evaluation of chemotherapy treatment

    Evaluation of Chemotherapy Treatment

    This is guided by a combination of published randomized clinical trials and the objective effects within the specific patient. In essence, physicians are looking for signs that the chemotherapy is having an effect on the cancer. In some cases, the chemotherapy may not have a detectable effect on the tumor until all of the initial cycles are

  • combination chemotherapy in advanced adrenocortical carcinoma

    Combination Chemotherapy in Advanced Adrenocortical Carcinoma

    The rate of compliance with the quality-of-life questionnaire was 67.1% at baseline (204 of all 304 patients) and 46.1% at the time of the first evaluation (129 of the 280 patients who were still